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Abstract 
Biomedical researchers are trained to use positivistic approaches to develop efficacious 
treatments and pursue cures for illness and disease. Accordingly, they rarely engage persons 
living with the disease in the development of research questions and protocols (Sacristán et al., 
2016). Just as patient narratives can create therapeutic partnerships in delivery of treatment 
(DasGupta & Charon, 2004), they offer value to the research process as a means to emphasize 
the person with the disease, rather than the disease, in isolation. We are interested in the role of 
patient stories as tools for influencing the biomedical research process (Greenhalgh, 2009; 
Panofsky, 2011). Applying Ellingson’s (2009) approach to crystallization in qualitative research, 
we explore intersections in the literature on patient advocacy, our own narratives, and those 
from biomedical researchers and patients. We seek to uncover the meaning of involving not 
only patients, but patients’ stories (Hyden, 1997), in creating an agenda for research in 
healthcare. 
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Introduction 
Adam: 
 Shuffling along, parallel to the buffet table, displaying gait instability and balancing a 
ceramic catering plate with my left hand, plagued by neuropathy and weakness, I steadied 
myself before hooking my cane over my left arm to grasp tongs in my functional right hand and 
serve myself salad. Feeling comfortable in my otherness, I shrugged when the diner before me 
offered to assist with assembling my meal. Whether motivated by pity, aid, or efficiency, she 
smiled with pursed lips and a sideways glance, lifted my plate from the table, and proceeded 
down the line. Although “patients included” is a recent and flashy biomedical conference trend, 
advances in biomedical research inclusivity remain passive and permissive rather than active 
and enabling. 
 The facilitator began the closing session by eliciting from the audience, “the most 
innovative developments you heard about or saw during the conference.” Augmented virtual 
reality microscopy was a crowd favorite. Participants continued, “gene editing!” another, “liquid 
biopsy!” Indeed, next followed structured “share outs” from prescribed topics to advertise all that 
we learned about genomics, biomarkers, and immunotherapies. 
 I wondered how this might be so: I was attending this conference by selection for a 
special scholarship and concomitant designation indicative of my role as a science-literate 
patient advocate. Though I knew only those 25 or 30 others I spoke with directly over the course 
of several days, ostensibly the program that evening, mandatory for those attending on 
scholarship, comprised a majority audience of others like me: other patients. Yet not a word 
spoken about the bedside. Not a topic for share out. Not a single line explicitly drawn between 
research innovation and patient experience. A buffet table of scientific expertise and a burden 
placed on the consumer to navigate, serving as a barrier to access. 
Krista: 
 I read Adam’s narrative, and immediately felt the dialectical tension he describes.  
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Maybe the conference participants were more excited about the scientific researchers?  Can 
you fault them?  They are researchers, after all.  At the same time, reading Adam’s story puts 
me in the room.  His point is made more salient by his metaphor--the inaccessible buffet of food 
and research findings.  Adam was hungry for participation, just as the researchers were hungry 
for new discoveries.  Reading this story, for me, as a scholar of communication, reminds me of 
the power of the narrative--how (re)storying the conversation of Adam’s role at the biomedical 
research conference brought to the fore the isolation patients potentially feel when asked to 
participate without an acknowledgement of their ways of knowing (Pearce, 1989).   
 With the two narratives above, we seek to illustrate our entry points in this topic--as a 
person living with brain cancer and philosopher of science, and a teacher and researcher of 
communication in academic medicine. In this chapter, we seek to use a mix of our own 
narratives and literature review to illumine lessons at the intersection of biomedical research 
and patient narratives which are, at best, left implicit, and at worst, neglected. Our method is 
patterned after the theoretical framework we espouse: first, advance a patient narrative, and 
second, interrogate its role in biomedical research advocacy.  
Biomedical researchers are usually trained to use positivistic approaches to develop 
efficacious treatments and pursue cures for illness and disease. Accordingly, they rarely engage 
persons living with the disease in the development of research questions and protocols (Caron-
Flinterman, Broerse, & Bunders, 2007; Sacristán et al., 2016). Just as patient narratives can 
create therapeutic partnerships in delivery of treatment (DasGupta & Charon, 2004), they offer 
value to the research process as a means to emphasize the person with the disease, rather 
than the disease, in isolation (Greenhalgh, 2009; Panofsky, 2011). Applying Ellingson’s (2009) 
approach to crystallization in qualitative research, we explore intersections in the literature on 
patient narratives in advocacy, our own narratives, and those from biomedical researchers and 
patients. We seek to uncover the meaning of involving not only patients, but more specifically, 
patients’ stories.  As Hyden (1997) argues, “[p]atients' narratives give voice to suffering in a way 
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that lies outside the domain of the biomedical voice” (p. 49). We offer tactics to close this gap 
and identify a role for narrative in creating an agenda for research in healthcare. 
 The roadmap for this chapter is as follows.  In the first section, we discuss the extant 
research on patient involvement and narrative in the context of biomedical research, and explain 
our methodological approach.  Next, we investigate the topic of expertise by considering the 
interplay of experiences and credibility as each informs the roles ascribed to “patients” and 
“researchers.”  We extend the conversation about experiences to promote narrative as a tool to 
introduce a non-positivistic way of knowing that undermines the presupposed objectivity of 
science. We survey limitations of our piece.  Finally, we offer concluding remarks. It is our aim to 
consider carefully the role of narrative, expertise, different ways of knowing in the pursuit of 
biomedical research, and ultimately health and healing. 
Patient Participation in Biomedical Research 
An investigation of the historical relationship between biomedical researchers and 
patients is helpful to better understand how patient narratives can inform the biomedical 
research process.  Over the past forty years, there has been a shift in discourse from 
understanding patients as subjects (merely one of many tools required to conduct biomedical 
research) to important participants in (and even powerful drivers of) biomedical research.  This 
shift can be attributed to both scientific and social influences (Caron-Flinterman, et al., 2007; 
Solomon, 2016).  As scientific problems have become more complex and connected to social 
forces (such as social determinants of health), scientists have sought to include more lived 
experiences of patients in the research process.  Additionally, the public has increasingly 
demanded the applicability of scientific discovery to lay people’s and patients’ lives.   
 Scientists and scholars tend to use two primary arguments for including patients in the 
research process (beyond serving as subjects).  The first argument is regarding improvement of 
the science itself.  Since patients have a type of experiential knowledge, their expertise can 
serve as a foil to the professional and objective work of scientists, thus creating a more 
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complete research outcome (Entwistle et al., 1998).  Alternatively, Collins and Evans (2002) 
contend that partnerships with patients in the biomedical research process enhances the moral 
and political legitimacy of the research, since they are ultimately the beneficiaries of this 
information. 
 Though recognized in the clinic, “health care can be delivered more effectively and 
efficiently if patients are full partners in the process” (Holman and Lorig, 2000, p. 527), the 
movement to involve more patients in the biomedical research process in the US is a relatively 
new phenomenon.  In 2003, Zerhouni, a former director of the National Institutes of Health 
(NIH), argued for a shift in clinical research to include more patients, specifically via community-
based physicians and organizations.  While no mention of patient narrative is present, the 
author clearly advocates for privileging patient voices in the research process, mentioning “new 
models of cooperation between NIH and patient advocacy alliances” (p. 64).  However, bridging 
the gap between patients and researchers is a hard-won process. Reporting for Nature News 
five years later, Butler (2008) questioned what the NIH had actually done to encourage the 
values they espoused. He explained,  
Over the past 30 or so years, the ecosystems of basic and clinical research have 
diverged. The pharmaceutical industry, which for many years was expected to carry 
discoveries across the divide, is now hard pushed to do so. The abyss left behind is 
sometimes labelled the 'valley of death' — and neither basic researchers, busy with 
discoveries, nor physicians, busy with patients, are keen to venture there. (p. 841) 
As illustrated by this report, simply giving a mandate for scientists, clinicians, and patients to 
communicate more effectively and creating “networks” (Zerouni, 2003) were not enough to 
bridge the gap between these communities.  With this example, it is important to note that 
disciplinary boundaries often shape the way that scholars understand a particular phenomenon.  
In the case of Zerouni’s (2003) mandate and Butler’s (2008) critique, these perspectives are 
legitimized in the biomedical research community, in part because of their affiliation with the NIH 
and the journal Nature.  Despite Butler’s (2008) critique, some scholars contend that biomedical 
researchers and patients have seen some successful partnerships. 
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  Caron-Flinterman and colleagues (2007) classified three categories of patient 
participation in biomedical research. They include (1) ithe lobbying of patient organizations, (2) 
ad hoc use of patients’ ideas and demands through intermediaries, and (3) inclusion of patient 
representatives in existing decision-making groups (as described in Adam’s story above).  
Although their study was conducted in the Netherlands, Caron-Flinterman et al. (2007) argue 
that their literature searches and participants give a “reasonable impression” of the landscape 
globally (p. 347).  Wehling et al. (2015) also address issues of typology, arguing that, although 
classification holds value, the level of diversity in disciplines and approaches may limit social 
scientists’ abilities to define the experiences of researchers’ and patients’ partnerships.   
More recent work by Kaye and colleagues (2012) acknowledges that current biomedical 
research models fail to adequately include the perspectives of patients and research 
participants.  The authors propose that new technology can facilitate participant-centered 
initiatives (PCIs), defined as “tools, programs and projects that empower participants to engage 
in the research process using IT (p. 4). They further argue that using PCIs through technology, 
such as patients sharing of data in social media and apps, can encourage ongoing interactions 
between participants and researchers.  As Kaye et al. explain, this approach “can result in 
research that demonstrates high standards of research integrity but also an involvement by 
patients and participants that is more active and richer than more conventional approaches” (p. 
5).   
 Imbedded in the models described above is a dialogic space between patients and 
biomedical researchers, where, in some cases, patient narratives are shared directly to the 
researchers and, in other cases, are shared via an intermediary (i.e. a researcher or physician 
sharing a patient’s story on behalf of the patient, or more recently, an app sharing data with a 
researcher in which the researcher constructs the story of a patient’s illness via the data 
received).  In any case, narrative is at the center of the interaction.  It is the primary tool patients 
have to engage with biomedical researchers.  However, as illustrated by Wehling et al. (2012), 
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patients, researchers, and physicians each approach their interactions with illness and the 
storying of illness quite differently.  One specific area where these epistemological differences 
manifest is in the context of objectivity. Writes Murphy et al., (2016), “the reality of patients is 
never directly encountered by a clinician, or anyone else, but is revealed gradually through the 
stories they tell” (p. 103). Murphy and colleagues (2016) remind us, “accumulating information 
about a patient is thus a hermeneutic exercise” (p. 103). 
What is the problem with objectivity?  
Biomedical researchers, even more so than physicians, are trained to privilege the 
perspective of objectivity.  Randomized controlled trials are seen as the so-called gold standard 
of biomedical research, where the goal is to eliminate bias and control for as many variables as 
possible.  When it is impossible to control for a variable, researchers treat this as a limitation of 
their work, caveating and listing these at the end of their studies.  Conversely, most physicians 
acknowledge that the practice of medicine is both a science and an art (Charon, 2006; 
Greenhalgh, 1999; Solomon, 2016).  Although many clinicians work within the paradigm of 
evidence-based medicine, Solomon (2005) notes that this term, itself, is political and subjective 
in nature.  The term, at best, can give epidemiologic data about a particular disease, but fails to 
offer much solace to patients who do not fit into the standard narrative of a particular disease (p. 
289). Narrative researchers move even further away from the objective paradigm.  As Chase 
(2003) explains, “[narrative] researchers develop meaning out of, and some sense of order in, 
the material they studied; they develop their own voice(s) as they construct others’ voices and 
realities” (p. 657).  The dialectic tension between objective and subjective are inherent in Japp 
and Japp’s (2005) investigation of the narratives of biologically invisible diseases.  As they 
explain, “[t]he pervasive hegemony of the biomedical model of disease limits the stories patients 
tell as much as it does physician’s practices” (p. 122).  
It is expected that these tensions may introduce significant worries for biomedical 
researchers for whom empirical evidence is the purported norm by which science progresses, 
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and it is only through these evidence-based methods that a proper objectivity toward a subject 
or domain of investigation is maintained. Though, the philosophy of science has long advanced 
the position that all observation is theory-laden (Hanson, 1958). More plainly, any observation or 
experimental design is selected with theory in mind. Theory selection itself is a social act. 
Philosophers of science Bertolaso and Sterpetti (2017) remind readers of the epistemic 
subjectivity of theory selection, favoring plausibility accounts replete with subjectivity rather than 
probabilistic accounts. When available evidence fails to adjudicate between rival theories, 
researchers employ so-called theoretical virtues to advance the preferred theory. Peter Lipton 
(2003) develops a robust account of theoretical virtues and their role in identifying scientific 
theories which are the most likely to be at least approximately true. 
Thus, the lines distinguishing subjectivity from objectivity in research are blurred, and 
clinging to the notion of purely objective science is unhelpful, particularly for patients and 
clinicians who experience the messiness of disease on a daily basis. Patient narratives should 
not be rejected out of hand for fear of their socially constructed nature. In order to move beyond 
the question of legitimacy of patient narrative in the understanding of biomedical research, it is 
useful to delve into the notion and definition of expertise.   
Who is an expert?  
When considering the role of patients and patient narratives in biomedical research, 
expertise becomes a significant area of contention.  In the traditional biomedical model of 
medicine (as embodied by most biomedical researchers), patient experience is often defined as 
“lay knowledge,” implying that it is epistemologically inferior to the expertise of researchers 
(Wehling, Viehover, & Koenen, 2015).  This perspective is situated in the larger grand narrative 
of the biomedical model (Epstein, 1995; Japp & Japp, 2005; Morris, 1998), where the primary 
actor is the researcher using science and technology to discover and cure the patient.  In this 
context, patients are objects of study upon which science is acted, rather than participants or 
co-creators of the outcome.  
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We suggest this model is mistaken on two accounts.  First, the transactional model of 
care seeks to cure, assuming an acute intervention, which is poorly suited for the management 
of chronic illness (Carel, 2008; Holman & Lorig, 2000). Second, viewing patients as end-users, 
or more crudely, “consumers” and “customers,” fails to notice that clinicians, for their part, are 
similarly caught up in the biomedical model, treating patients in the clinic or at the bedside, as 
mere “providers” (Montori, 2017, p. 79ff.) This model leaves little space for inclusion of the 
patient narrative.  Clinician narratives further punctuate the loss of autonomy experienced by 
both “providers” and “consumers” of healthcare.   
When patients have engaged with biomedical researchers, the language of biomedicine 
is privileged.  Epstein’s (1995) participants in the AIDS treatment movement described this as 
learning a foreign language. His participants noted that, once they had access to the language 
of biomedicine, they could access and influence the institutions.  In other words, “Once they 
could converse comfortably about viral assays and reverse transcription and cytokine regulation 
and epitope mapping, activists increasingly discovered that researchers felt compelled, by their 
own norms of discourse and behavior, to consider activist arguments on their merits” (Epstein, 
1995, p. 419).  As Wehling and colleagues (2015) explain, it is in this space where the definition 
of expertise becomes most murky.  The authors state, “...to what extent and in what 
circumstances is patients’ knowledge complementary to and instrumental for scientific 
knowledge production, and how far is it opposed to it, contesting its background assumptions 
and conceptual approaches and transforming the latter?” (p. 5).  Shapin (1990) notes that the 
constitution of the expert/lay divide is defined by the question of who possesses cultural 
competence; thus, asking researchers to posit what a space for productive exchange of 
experience and ideas between biomedical researchers and patients might look like.   
As earlier mentioned, Japp and Japp’s (2005) discussion of legitimacy of patients’ 
experiences offer a grim description of the current space for conversation.  Because patient 
narratives are told within the social and political context of the grand narrative of biomedicine, 
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patients are simultaneously constrained and enabled when telling their stories.  Technical 
rationality is privileged, leaving patients who do not fit into the traditional narrative often feeling 
lost and delegitimized.  In this postmodern perspective, counternarratives emerge from patients 
who question the dichotomy between illness and cured, seeking a space of demedicalization of 
their experiences  (Harter, Japp, & Beck, 2005).  Pearce’s work (1985) on coordinated 
management of meaning is potentially helpful here, to both biomedical researchers and 
patients, to explain how these tensions have been created.  As the author contends, each 
communicative community holds its own set of resources and practices, that are often not easily 
accessible to those outside the group.  When this happens, conflict emerges and conversation 
can often devolve. As Pearce (1989) explains,  
In speaking to those who logics of meaning and action are similar to their own, persons 
use a sophisticated vocabulary, acknowledge the dignity and honor of those who 
disagree with them, and usually are able to put together well-coordinated episodes. 
However, when speaking to someone from another group, the form of discourse 
attenuates quickly.  A simplified vocabulary is used; the personalities and motives of the 
other are posed in a desiccated vocabulary of human purposes; taunts and 
condemnations replace argument and evidence; and one’s own reasoning and life 
experiences are protected from exposure and anticipated criticism. (p. 43-44) 
Because one communicative community’s (biomedical researchers) resources and practices 
have been traditionally privileged, it is no surprise that the narratives of another community 
(patients) have been generally seen as unhelpful.  Conversational actors constantly co-
construct the meaning of communication as they communicate, and as such, particular roles 
have been reified.  For biomedical researchers, it is the role of expert, as defined above.  In the 
case of patients, the sick role has emerged as another dominant narrative. 
The sick role 
Following the July 2017 brain cancer diagnosis of American high profile political figure, 
Senator John McCain, public awareness spread concerning the aggressive and deadly cancer, 
glioblastoma, usually abbreviated as its medical moniker, “GBM.”  This devastating disease 
corners patients with no available curative treatment, left to confront a limited life expectancy 
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and generally poor quality of life.  Living with GBM requires patients endure side effects from 
cytotoxic cancer therapeutics and neurological disorders stemming from tumor invasion and 
neurosurgical removal of the primary brain tumor--the first step in the standard of care protocol. 
Adam:  
I received a GBM diagnosis in June 2016, one year prior to Mr. McCain’s.  For this 
reason, beyond the sympathetic reaction shared by many, I paid close attention to media 
coverage surrounding the health communication tactics and information dissemination of this 
rare and difficult to understand disease.  That month was especially hot.  My family vacationed 
with close friends near a lake in Southern Indiana, a day’s trip from our home.  Seeking refuge 
from the heat and taking active steps to manage my seizures, I chose not to join in a planned 
trip to a nearby amusement park. I spent much of the morning comfortable in a rocking chair set 
on the shaded porch of our rented cabin, reading.  I decided to retreat inside to lie down when I 
heard the familiar tone of a smartphone notification.  News broke of Mr. McCain’s diagnosis. 
Several friends and acquaintances reached out to notify me. 
 Carel (2008), a philosophy scholar living with a chronic illness, provides an extensive 
account of the phenomenology of illness. The author contrasts the philosophical treatment of 
the illness experience as a foil to the ‘naturalistic’ model of illness and disease paradigmatic of 
the biomedical research community. Carel (2008) goes to some length situating illness in a 
social context, describing illness as problematic in at least two ways.  First, illness punctuates 
the ill person’s inability to control how others view them, and second, all social interactions are 
placed in the shadow cast by illness. On Carel’s view, it is not surprising that associations 
between McCain’s diagnosis and my illness immediately presented themselves to others, 
prompting outreach.  As I wrote in an open letter to McCain (Hayden, 2017), there is little 
McCain and I share in social position or common interest, yet each is now connected by a 
specific disease.  That connection in isolation is connection enough to reshape my social 
position as a peer of McCain’s, a position unlikely to emerge without the social implications of 
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becoming ill.  Indeed, Carel evokes Parsons’ (1951) account of this feature of illness: the sick 
role. 
 In a sociological rather than philosophical context, Parsons (1951) emphasized features 
of disease (later echoed by Carel (2008)). Parsons was quick to contrast biological processes of 
illness from sociological considerations. His novel construction of illness described the “sick 
role” as a “deviant role,” that is, failing in some way to fulfill the institutionally defined 
expectations of one or more of the roles in which the individual is implicated in the society” (p. 
452). In my letter to McCain, I contrast his age, storied persona as Vietnam prisoner of war, and 
notable history serving in the American Senate, with my youth, young fatherhood, and non-
political background. McCain and I are deviant in our illness; we share a sick role, in so far as 
we are each rendered weak and vulnerable by disease, failing our implicated societal roles. 
McCain fails his implicated role as battle-tested, strong, and courageous political leader. I fail 
my implicated role, as a young person, nearly 50 years McCain’s junior, expressing the vitality 
as a father with very young children. 
Krista: 
I remember reading Adam’s letter to Senator McCain when it came out.  As a publication 
venue, STAT is a “big get” for those of us in the communicating science and health world.  I was 
proud to say I knew him.  How sad is that?  That I was proud to have a friend doing such 
amazing and high-profile work, as a result of a terrible diagnosis.  In reading this again, I can 
see how I fall into these patterns.  Communicatively, I work hard to identify Adam as a scholar 
and philosopher first, a “sick person” second.  I often wonder if this matters discursively.  Since 
we travel in many of the same circles, I worry (maybe I shouldn’t?) about Adam being known as 
“the guy with the brain tumor,” essentializing his identity into his diagnosis.  Largely speaking, 
this is always a concern of mine for anyone living outside the dominant narrative.  How do we 
honor these stories, without constantly othering?  And how, as an educator of current and future 
biomedical researchers, do I teach people how to do (or not do) this?  
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 Parsons (1951) and Carel (2008) each distinguish two paradigms of illness: one, 
naturalistic (positivistic, reductionist, or biological), and the other, sociological or 
phenomenological. Features of the illness experience fail to be captured by a purely empiricist 
account of disease. The issue, then, expressed recently by Wehling and colleagues (2015), is to 
define how best to relate patient knowledge--the “sick role,” or phenomenological--to scientific 
knowledge--positivistic. In violating these sick roles, both McCain and Hayden create a 
counterstory to the master narrative of the biomedical construction of illness, identifying them as 
whole people who, alongside their identity within the GBM community, still assert their identities 
as fathers and professionals (Japp & Japp, 2005). This introduction of additional lenses moves 
the reader to see the storyteller as more than just a “sick person.”   
With these perspectives in mind, we offer the tactic of narrative as a tool to move 
biomedical researchers away from the biomedical construction of illness, viewing patient 
narratives as both a tool to inform research and an epistemological lens to understand the 
diseases they study in a new way. If we understand illness as codified through discourse, even 
in the context of biomedical research, introducing the illness experience into the research 
community could actually change the research questions. 
Reimagining the Role of Narrative and Storytelling 
 Scholars of health communication, sociology, medicine, public health, and other 
disciplines have considered the role of patient narratives as a tool for conducting or informing 
research.  Some (such as Borkan, Quirk, & Sullivan, 1991) use the gathering of patient 
narratives as a research methodology or narrative inquiry (Chase, 2003) in an attempt to 
consider the relationship between patient perceptions and health outcomes. Psychiatrist and 
narrative theorist Adler (2012) notes a critical role for narrative as tool for patient agency, or in 
Adler’s words, “autonomy, achievement, mastery, and ability to influence the course of his or 
her life” (p. 368).  As this volume and others researchers (Charon, 2006; Epstein, 1993; Harter, 
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Japp, & Beck, 2005; Wehling et al., 2015) extole, narrative is a critical tool in redefinining the 
roles of patients and those who treat them. 
However, many of these scholars acknowledge that narratives do not exist only in the 
context of the interpersonal relationship between the storyteller and the listener (physician, 
biomedical researcher, or otherwise).  For example, Japp, Harter, and Beck (2005) examine the 
role of narrative in constructing and co-constructing the ontological meaning of health and 
disease.  As they explain,  
Personal narratives become the building blocks of public knowledge. More and more, 
mediated and public dialogue, from legislative testimony to newscasts to public health 
promotion, rely on individual stories to embody problems, shape arguments, and engage 
emotions, as well as to persuade, evaluate, reward, and punish. (p. 3) 
This quotation and the work of others (Epstein, 1993; Japp & Japp, 2005) illustrates the extent 
to which patient narratives are not only an object for researchers to analyse.  Rather, the 
narratives, themselves, shape and are shaped by the research context in which they are 
collected and told.   
The role of narrative in biomedical research and patient care is subject to critique.  Some 
scholars contend that narratives in medical research can be “susceptible to the narrative fallacy 
(i.e., causal hypotheses are too readily constructed from sequences of events) and to the 
influence of constraining politically dominant narratives” (Segal, 2007, p. 290).  Harter and 
colleagues (2005) echo this concern, reminding their readers that “[n]arratives are shaped within 
certain beliefs and value systems, and serve to reinforce or challenge those systems as they 
are constituted in social interaction” (p. 23).  Thus, examining the context, as well as the 
narrative, is an important part of understanding its potential for influence. A further, related, 
concern notes that narratives are constructed with an audience in mind, and the audience, or 
listener, is active in meaning-making as co-creators (Pearce, 1985; Spencer, 2017).  Given the 
importance of narrative context, here, we reconsider the role of objectivity and subjectivity in the 
narrative relationship between biomedical researchers and patients.  
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In the late 1990s, Epstein, a sociologist with a focus on science and technology, closely 
examined the role of AIDS activists in driving the agenda for biomedical research, specifically 
the testing of new pharmaceutical treatments.  Epstein’s (1995) work illustrates the complicated 
role of narrative in the relationship between biomedical researchers and patients. The author 
posits that, although AIDS activists were able to use their lived experience to influence the 
research process, they could not fully reject the biomedical model of their disease because of 
their need to know which treatments were most efficacious.  Citing Richard’s (1991) argument 
for more relativism in the biomedical research process, Epstein explains, “[t]he activist critique 
of the randomized clinical trial unseats that methodology from the pinnacle on which it is 
sometimes placed, but it also assumes a greater role for such trials than analysts such as 
Richards would recommend” (p. 425).  While Epstein considers this a departure between the 
views of researchers and patients, we see this as a potential place of common ground.   
As much as objectivity has a place in the lab and the testing of hypotheses, subjectivity 
is inherent to biomedical researchers decisions to choose what to study.  Most researchers 
enter into a field of study because they are excited about the possibility of curing a disease or 
helping patients.  This, in itself, is an emotional or subjective act.  Many research societies invite 
patients (like Adam) to their meetings to tell the stories of their experiences.  More than ever, 
researchers are asked to pursue funding from private foundations often started by family 
members or those with complex diseases themselves.  Thus, patients’ stories are already 
present in the minds of researchers when they pursue a research question. 
Patient narrative can be seen as a tool to help biomedical researchers see beyond the 
“reductionist lens” of randomized clinical trials (Caron-Flinterman et al., 2007).  The role of 
narrative in the biomedical research process does not have to be an either-or assumption.  After 
all, the messiness of the narrative can potentially inform the way in which we approach 
researching illnesses, which are (almost by definition) also messy in their constitution.  Cancer 
doesn’t appear with the same symptoms for every patient; different cancers behave differently, 
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and we still don’t know why; the way in which cancer affects patients lives is unique for each 
person and each family member.   
Most patients would not advocate for biomedical researchers to fully dispose of the 
scientific methodology they use to test treatments (Epstein, 1993).  Rather, they would prefer to 
see treatments tested within the context of real life.  With this in mind, we envision a space 
where biomedical researchers invite the patient experience more fully into their thinking about 
scientific questions.  Dahlstrom’s (2014) work on the use of narrative in science communication 
with lay audiences offers a paradigm that, when combined with Pearce’s (1989) coordinated 
management of meaning, could create the dialogic space we seek to create between 
researchers and patients.   
Taking a social scientific approach, Dahlstrom’s (2014) argues that narrative could be a 
particularly useful tool in explaining complex scientific concepts to lay audiences.  The author 
combines extant research about narrative, science communication, and media to illustrate that 
narrative content about scientific topics is more likely to be remembered and shared by 
consumers.  Dahlstrom (2014) concludes his exploration with a call for research on 
communicating scientific concepts that are “beyond the human scale” (p. 13618); phenomena 
which are beyond our perceivable reality, for example, things “as large as climate change, as 
small as parts per billion, or as distant as 10,000 y away” (p. 13618).  However, for biomedical 
researchers, the lived experience of disease is, potentially, beyond their scale.  If they have not 
lived with the illness themselves, it is a struggle for researchers to fully know or understand the 
experiences of patients living with the diseases they hope to cure.  Empathy and inquiry are 
invited through story.  Pearce (1989) advances the concept of narrative between groups, 
arguing that, if we are coordinating meeting with one another, we must seek to understand the 
stories that constitute our experiences.  As Pearce (1989) explains, we must first recognize our 
communication as fundamentally part of our own group, if we are to understand the experiences 
of others.  Then, we must strive for a form of communication that values the other; a form called 
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“cosmopolitan communication.”  The author states, “tolerance for difference liberates 
cosmopolitan communicators to care about and take steps to find out about worldviews other 
than their own” (p. 193).  Combining these two perspectives, we envision a dialogic community 
where both biomedical researchers and patients open themselves to the resources and 
practices of their speech communities.  Narrative is a tool that can help biomedical researchers 
adjust the scale of illness, seeing patients as part of the process required for knowing a disease, 
in all its forms.  
Conclusions and Limitations 
 Here, we sought to identify a gap in biomedical research: namely, the absence of the 
patient voice, vis-a-vis patients’ narratives, or their stories.  In doing so, we argue that closing 
this gap offers a fruitful tactic to improve biomedical research by placing the researcher and the 
research product in dialogue with the consumer, in this case, a patient. Incorporating patients’ 
narratives into the research process introduces an uncomfortable dialectical tension between 
the purported objectivity of scientific methodology, on the one hand, and the subjective, 
interpretive work of telling and hearing stories, on the other.  We hope to diffuse this tension by 
pointing to the ineliminable epistemic subjectivity of scientific experimental design and 
observation.  In other words, researchers need not fear the spectre of subjectivity; they need 
only to understand it. 
 Ultimately, this chapter offers an extended argument in support of the central thesis that 
inquiry is best practiced with a pluralistic attitude toward expertise; call this lay or experiential 
knowledge, as some authors have, or phenomenological or sociological, as expressed by 
others. Independent of which term of art is preferred, eliciting patients’ narratives, specifically in 
the context of biomedical research, is an effective means of considering different ways of 
knowing. 
Raising the patient voice in a new setting is not without controversy. The deviancy of 
patient narratives is punctuated by Carel (2008) and Parsons’ (1951) emphasis on the sick role. 
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One limitation of this piece is its tacit promotion of such deviancy. The argument in this chapter, 
if accepted, is an critique of the dominant paradigm in biomedical research, communicated best 
through a meta-narrative framed by positivistic assumptions. 
 Wehling and colleagues (2015) raise a concern articulated by Blume (2010), which is 
germane: patients only gain credibility insofar as their demands are compatible with 
fundamental assumptions of medical science. This concern is raised within a different 
framework in a concise survey of objections raised by medical professionals in training against 
the pedagogical practice of incorporating the humanities in medical education: a discussion 
inextricably linked to applying the same pedagogical tactic in biomedical research. Without 
compatibility with dominant background assumptions, narratives may appear uninformed, if not 
hostile. Shapiro and colleagues (2009), report a complaint raised by a medical student, 
critiquing a required humanities course in his medical school curriculum. Relates Shapiro et al. 
(2009), “[t]his young man and students like him feel a sense of grievance: it’s unfair to be 
evaluated in an area they hadn’t expected to be part of their curriculum” (p. 193).  
Whether addressing students, clinicians, or researchers, confronting an accepted 
paradigm is often met with a hostile and defensive posture, creating the us-them mentality 
described in Pearce’s (1989) work.  In support of our deviance from the dominant paradigm and 
support of a new dialogic space for biomedical researchers and patients, we repeat a lesson 
explicated by Murphy and colleagues (2016), “patients always present an illness… this process 
is not disinterested but includes perspectives, values, and commitments. A presentation is 
always motivated and expresses an angle or disposition. Nothing can remove symptoms from 
these entanglements, even the most sophisticated laboratory tests” (Murphy et al., 2016, p. 
104).  As illustrated by these examples, biomedical research benefits from incorporating diverse 
angles or dispositions, learned through attention to patients’ narratives. 
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